Compare ASLE & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASLE | LAB |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.8M | 354.1M |
| IPO Year | 2018 | 2008 |
| Metric | ASLE | LAB |
|---|---|---|
| Price | $6.31 | $0.91 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.00 | $1.35 |
| AVG Volume (30 Days) | 271.7K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.64 | 61.54 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $335,286,000.00 | $101,937,000.00 |
| Revenue This Year | $23.41 | N/A |
| Revenue Next Year | $6.80 | $2.63 |
| P/E Ratio | $35.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.56 | $0.88 |
| 52 Week High | $9.08 | $1.72 |
| Indicator | ASLE | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 34.74 |
| Support Level | $5.67 | N/A |
| Resistance Level | $6.56 | $1.01 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 79.79 | 28.61 |
AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.